Glaxosmithkline Phar - Quarterly Results
29th Jul 2020

The sales for the June 2020 quarter moved down to Rs. 6486.50 millions as compared to Rs. 7880.20 millions during the year-ago period.A slender decline of -2.20% was recorded to Rs. 1109.60  millions from Rs. 1134.60 millions in the corresponding previous quarter.A decline of 1721.40 millions was observed in the OP in the quarter ended June 2020 from 1960.20 millions on QoQ basis.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  202006 201906 % Var 202006 201906 % Var 202003 201903 % Var
Sales 6486.50 7880.20 -17.69 6486.50 7880.20 -17.69 32246.80 31285.30 3.07
Other Income 577.90 305.40 89.23 577.90 305.40 89.23 775.60 1014.80 -23.57
PBIDT 1721.40 1960.20 -12.18 1721.40 1960.20 -12.18 7360.10 7079.60 3.96
Interest 10.80 9.30 16.13 10.80 9.30 16.13 63.40 5.50 1052.73
PBDT 1710.60 1950.90 -12.32 1710.60 1950.90 -12.32 4051.80 7123.00 -43.12
Depreciation 217.70 190.60 14.22 217.70 190.60 14.22 826.80 485.90 70.16
PBT 1492.90 1760.30 -15.19 1492.90 1760.30 -15.19 3225.00 6637.10 -51.41
TAX 383.30 625.70 -38.74 383.30 625.70 -38.74 2124.50 2383.50 -10.87
Deferred Tax 2.20 61.60 -96.43 2.20 61.60 -96.43 -477.20 455.30 -204.81
PAT 1109.60 1134.60 -2.20 1109.60 1134.60 -2.20 1100.50 4253.60 -74.13
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 26.54 24.88 6.69 26.54 24.88 6.69 22.82 22.63 0.86